Treatment of central serous chorioretinopathy with topical NSAIDs
Clicks: 332
ID: 6961
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
70.3
/100
332 views
228 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #10 of 32 articles by views in clinical ophthalmology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Treatment of central serous chorioretinopathy with topical NSAIDs Sepehr Bahadorani,1 Kyle Maclean,1 Kendall Wannamaker,1 Edward Rickie Chu,1 Nathan Gresores,2 Jeong-Hyeon Sohn,1 Roberto Diaz-Rohena,1 Michael A Singer21Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA; 2Medical Center Ophthalmology Associates, San Antonio, TX, USACorrespondence: Michael A SingerMedical Center Ophthalmology Associates, 9157 Huebner Road, San Antonio, TX 78240, USA Tel +1 210 697 2020 Email msinger
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (65 words).
Try re-searching for a better abstract.
| Reference Key |
bahadorani2019treatmentclinical,
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | |
| Journal | clinical ophthalmology |
| Year | 2019 |
| DOI |
10.2147/OPTH.S202047
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.